ask="3.10"
ask_size="600"
average_daily_volume="95498"
bid="2.50"
bid_size="1000"
book_value="2.84"
change="+0.40"
change_from_200_day_moving_average="-0.88"
change_from_50_day_moving_average="0.58"
change_from_52_week_high="-3.39"
change_From_52_week_low="1.00"
change_in_percent="+15.38%"
close="3.00"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.04"
ebitda="-37.85M"
eps_estimate_current_year="-1.83"
eps_estimate_next_quarter="-0.30"
eps_estimate_next_year="-1.12"
ex_dividend_date="N/A"
float_shares="5860000"
high="3.10"
high_52_weeks="6.39"
last_trade_date="2/21/2017"
last_trade_price="3.00"
last_trade_size="260"
last_trade_time="4:00pm"
low="2.69"
low_52_weeks="2.00"
market_capitalization="63.62M"
moving_average_200_day="3.88"
moving_average_50_day="2.42"
name="Strongbridge Biopharma plc"
notes="N/A"
one_year_target_price="14.33"
open="2.75"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-22.61%"
percent_change_from_50_day_moving_average="+24.21%"
percent_change_from_52_week_high="-53.05%"
percent_change_from_52_week_low="+50.00%"
previous_close="2.60"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.91"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21205000"
short_ratio="0.76"
stock_exchange="NMS"
symbol="SBBP"
volume="115593"
weeks_range_52="2.00 - 6.39"
